NPM Sacks
Royal Marsden NHS Foundation Trust · 36 works · 2,247 citations · h-index 19
Top works
- Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.
- A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)
- High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer.
- HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer.
- Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer.
- The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19
- Family history of breast cancer: what do women understand and recall about their genetic risk?
- The Royal Marsden Hospital pilot tamoxifen chemoprevention trial
- Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer
- Satisfaction with clinical nurse specialists in a breast care clinic: questionnaire survey
- Cyclooxygenase-2 (COX-2), aromatase and breast cancer:a possible role for COX-2 inhibitors in breast cancer chemoprevention
- The detection of axillary lymph node metastases from breast cancer by radiolabelled monoclonal antibodies: a prospective study
- Familial cancer syndromes
- Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy
- Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration
- Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer
- Understanding the experience of prophylactic bilateral mastectomy: a qualitative study of ten women
- Radioimmunolocalisation in breast cancer using the gene product of c-erbB2 as the target antigen
- Evaluation of MSA as a serum marker in breast cancer: A comparison with CEA
- Mechanisms of hormone response: a role for apoptosis